Last reviewed · How we verify

Breztri Aerosphere

Jianxing He · FDA-approved active Small molecule Quality 5/100

Breztri Aerosphere is a Small molecule drug developed by Jianxing He. It is currently FDA-approved.

At a glance

Generic nameBreztri Aerosphere
SponsorJianxing He
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Breztri Aerosphere

What is Breztri Aerosphere?

Breztri Aerosphere is a Small molecule drug developed by Jianxing He.

Who makes Breztri Aerosphere?

Breztri Aerosphere is developed and marketed by Jianxing He (see full Jianxing He pipeline at /company/jianxing-he).

What development phase is Breztri Aerosphere in?

Breztri Aerosphere is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing